Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Clinical and Biological Sciences Department,
Neurology Unit,
Clinical and Biological Sciences Department, Neurology Unit
Marinella Clerico has not added Biography.
If you are Marinella Clerico and would like to personalize this page please email our Author Liaison for assistance.
High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study.
Journal of the neurological sciences Jul, 2004 | Pubmed ID: 15240190
The importance of maintaining effective therapy in multiple sclerosis.
Journal of neurology Sep, 2005 | Pubmed ID: 16170500
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
Neurology Dec, 2006 | Pubmed ID: 17190964
Interferon-beta1a for the treatment of multiple sclerosis.
Expert opinion on biological therapy Apr, 2007 | Pubmed ID: 17373904
Adherence to interferon-beta treatment and results of therapy switching.
Journal of the neurological sciences Aug, 2007 | Pubmed ID: 17376486
The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.
Clinical neurology and neurosurgery Nov, 2008 | Pubmed ID: 18164542
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.
Journal of neurology Sep, 2008 | Pubmed ID: 18825438
Risk factors for tumor occurrence in patients with myasthenia gravis.
Journal of neurology Aug, 2009 | Pubmed ID: 19330280
T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
Annals of neurology May, 2009 | Pubmed ID: 19475668
Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.
Journal of neuroimmunology Sep, 2010 | Pubmed ID: 20573405
Th17 cells in multiple sclerosis express higher levels of JAK2, which increases their surface expression of IFN-γR2.
Journal of immunology (Baltimore, Md. : 1950) Feb, 2012 | Pubmed ID: 22219326
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
BMC neurology Mar, 2012 | Pubmed ID: 22390218
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study).
JAMA neurology Aug, 2014 | Pubmed ID: 24977406
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.
JAMA neurology Sep, 2014 | Pubmed ID: 25048026
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β.
Journal of leukocyte biology Dec, 2014 | Pubmed ID: 25097195
Epigenetic therapy for Friedreich ataxia.
Annals of neurology Oct, 2014 | Pubmed ID: 25159818
Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.
Journal of neurology Dec, 2015 | Pubmed ID: 26410746
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months.
Neurology(R) neuroimmunology & neuroinflammation Feb, 2016 | Pubmed ID: 26819963
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
Expert opinion on drug delivery Jul, 2016 | Pubmed ID: 26909646
Influence of cigarette smoking on ALS outcome: a population-based study.
Journal of neurology, neurosurgery, and psychiatry Nov, 2016 | Pubmed ID: 27656044
University of Torino, San Luigi Gonzaga Hospital
Pierangelo Barbero1,
Marco Busso2,
Carlo Alberto Artusi1,
Stefania De Mercanti1,
Marco Tinivella3,
Andrea Veltri2,
Luca Durelli1,
Marinella Clerico1
1Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital,
2Oncology Department, Radiology Unit, University of Torino, San Luigi Gonzaga Hospital,
3Clinical and Biological Sciences Department, Dietologic and Nutrition Unit, University of Torino, San Luigi Gonzaga Hospital
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved